The West Virginia case is seen as a win for drugmakers following a U.S. Supreme Court setback earlier in the month, but the ...

"Public broadcasting is more than television and radio—it is a lifeline, a classroom, and a platform for candid dialogue and ...

The drugmaker is following in the footsteps of Johnson & Johnson and Eli Lilly in filing suit to force through controversial ...

The lawsuits center on the federal 340B drug discount program, which requires drugmakers that receive federal Medicare and ...

The Michigan Senate’s recent passage of Senate Bill 1179, aimed at regulating the federal 340B program, could be ...

HRSA warns Sanofi that its credit model for 340B drugs violates the statute, demanding immediate cessation to avoid penalties ...

Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to ...

The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate ...

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via ...

Drug manufacturers are trying to undermine the 340B program to evade their legal responsibility to provide discounts that ...